Identification and initial SAR of silybin: An Hsp90 inhibitor

Through Hsp90-dependent firefly luciferase refolding and Hsp90-dependent heme-regulated eIF2α kinase (HRI) activation assays, silybin was identified as a novel Hsp90 inhibitor. Subsequently, a library of silybin analogues was designed, synthesized and evaluated. Initial SAR studies identified the essential, non-essential and detrimental functionalities on silybin that contribute to Hsp90 inhibition.Figure optionsDownload full-size imageDownload as PowerPoint slide

Graphical abstractFigure optionsDownload full-size imageDownload as PowerPoint slide